Literature DB >> 7274305

Differential adriamycin distribution to blood components.

T Colombo, M Broggini, S Garattini, M G Donelli.   

Abstract

The differential distribution of doxorubicin (Adriamycin = AM) and daunorubicin (Daunomycin = DM) within the blood components, after an i.v. injection of 10 or 15 mg/kg of body weight, was investigated from its metabolites and quantified by means of the TLC scanning fluorescence technique. AM accumulated in the following order (of decreasing percentages): plasma and red cells (RBC), white cells (WBC), and platelets (PT), but the absolute amount of drug that reached each cell type was related to its relative volume. In the presence of higher blood concentrations (after injection of 15 mg/kg of body weight) the RBCs accumulated much more AM than the plasma, WBC, and PT; suggesting that the RBC fraction has a greater capacity to concentrate the drug. However, if the concentration of AM is expressed per unit volume of each component, a markedly higher value was observed for PT, and this was confirmed by in vitro results obtained by incubating blood in the presence of AM. DM seemed to be distributed on a percent basis to a greater extent than AM in the RBC fraction. Both compounds were taken up by blood cells, particularly platelets, to levels in excess of the extracellular concentration.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7274305     DOI: 10.1007/BF03189477

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  30 in total

1.  Affinity of adriamycin to phospholipids. A possible explanation for cardiac mitochondrial lesions.

Authors:  M Duarte-Karim; J M Ruysschaert; J Hildebrand
Journal:  Biochem Biophys Res Commun       Date:  1976-07-26       Impact factor: 3.575

2.  Accumulation of basic drugs in 5-hydroxytryptamine storage organelles of rabbit blood platelets.

Authors:  M Da Prada; A Pletscher
Journal:  Eur J Pharmacol       Date:  1975 Jun-Jul       Impact factor: 4.432

3.  The accumulation and metabolism of dopamine by the human platelet.

Authors:  H M Solomon; N M Spirt; W B Abrams
Journal:  Clin Pharmacol Ther       Date:  1970 Nov-Dec       Impact factor: 6.875

4.  Daunorubicin metabolism by human hematological components.

Authors:  D H Huffman; N R Bachur
Journal:  Cancer Res       Date:  1972-03       Impact factor: 12.701

5.  Subcellular distribution of some phenothiazines in blood platelets of rabbit.

Authors:  E Solatunituri; L Ahtee
Journal:  J Pharm Pharmacol       Date:  1968-04       Impact factor: 3.765

6.  Studies on the uptake of (I- 14 C)ascorbic acid and (I- 14 C)-dehydroascorbic acid by platelets of guinea pigs.

Authors:  D Hornig; F Weber; O Wiss
Journal:  Clin Chim Acta       Date:  1971-06       Impact factor: 3.786

7.  Adsorption to human red blood cells of chlorambucil and other biological alkylating agents.

Authors:  J H Linford; W Hryniuk; L G Israels
Journal:  Biochem Pharmacol       Date:  1969-10       Impact factor: 5.858

8.  In vitro DNA and RNA synthesis by human platelets.

Authors:  G Agam; H Bessler; M Djaldetti
Journal:  Biochim Biophys Acta       Date:  1976-02-18

9.  Binding-site interaction of chlorthalidone and acetazolamide, two drugs transported by red blood cells.

Authors:  B Beermann; K Hellström; B Lindström; A Rosén
Journal:  Clin Pharmacol Ther       Date:  1975-04       Impact factor: 6.875

10.  The accumulation of guanethidine by human blood platelets.

Authors:  D J Boullin; R A O'Brien
Journal:  Br J Pharmacol       Date:  1969-01       Impact factor: 8.739

View more
  4 in total

Review 1.  Role of red blood cells in pharmacokinetics of chemotherapeutic agents.

Authors:  Dirk Schrijvers
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.

Authors:  J Bouma; J H Beijnen; A Bult; W J Underberg
Journal:  Pharm Weekbl Sci       Date:  1986-04-25

3.  Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice.

Authors:  Rui Xue Zhang; Tian Zhang; King Chen; Ji Cheng; Paris Lai; Andrew M Rauth; K Sandy Pang; Xiao Yu Wu
Journal:  J Vis Exp       Date:  2017-10-05       Impact factor: 1.355

4.  Exploring the Interplay between Drug Release and Targeting of Lipid-Like Polymer Nanoparticles Loaded with Doxorubicin.

Authors:  Tatyana Kovshova; Nadezhda Osipova; Anna Alekseeva; Julia Malinovskaya; Alexey Belov; Andrey Budko; Galina Pavlova; Olga Maksimenko; Shakti Nagpal; Svenja Braner; Harshvardhan Modh; Vadim Balabanyan; Matthias G Wacker; Svetlana Gelperina
Journal:  Molecules       Date:  2021-02-05       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.